Related Experiment Video
Updated: Mar 22, 2026
22:10
Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
13.8K
Multitarget Drug Discovery and Polypharmacology
Maria Laura Bolognesi1, Andrea Cavalli2,3
1Dipartimento di Farmacia e Biotecnologie, Alma Mater Studiorum - Università di Bologna, via Belmeloro 6, Bologna, 40126, Italy. marialaura.bolognesi@unibo.it.
Chemmedchem
|April 11, 2016
Summary
This special issue explores polypharmacology, where single drugs target multiple molecules. This approach offers advantages over traditional single-target drugs in treating complex diseases.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Pharmacology
Background:
- The traditional "one target, one drug" paradigm is being challenged.
- Polypharmacology involves designing single molecules to interact with multiple biological targets.
- This approach is increasingly recognized for its potential in treating complex diseases.
Discussion:
- This ChemMedChem Special Issue highlights successful applications of polypharmacology.
- Single molecules engaging multiple targets can offer therapeutic advantages.
- Examples demonstrate the value of this strategy in drug development.
Key Insights:
- Drug discovery is shifting towards multitarget drug design.
- Polypharmacology can lead to more effective treatments for various pathologies.
- Understanding and utilizing drug promiscuity is crucial.
Outlook:
- Future drug discovery efforts should prioritize polypharmacology.
- Further research into multitarget drugs is warranted.
- This approach holds promise for addressing unmet medical needs.
Related Concept Videos
01:26Drug Discovery: Overview
12.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.9K
01:29Pharmacogenomics: Identification of New Drug Targets
75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
01:26Targets for Drug Action: Overview
11.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
11.2K
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
106
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
106
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
104
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
104
01:24Principles of Drug Action
9.3K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.3K